OKYO Pharma logo

OKYO - OKYO Pharma News Story

10.13p -0.1  -1.2%

Last Trade - 18/09/20

Sector
Healthcare
Size
Small Cap
Market Cap £64.4m
Enterprise Value £64.3m
Revenue £n/a
Position in Universe 1091st / 1807

BUZZ-OKYO Pharma jumps after co to present data demonstrating potential of OKYO-0101 for dry eye treatment

Thu 7th March, 2019 8:59am
** Biotechnology company OKYO Pharma Ltd  OKYO.L  jumps 15.2
pct after announcing it will present pre-clinical data
demonstrating potential of OKYO-0101 for dry eye treatment
    ** Stock second top gainer on LSE 
    ** Co says increase in corneal permeability due to dry eye
was reduced significantly by topical treatment with OKYO-0101 as
compared to vehicle group  urn:newsml:reuters.com:*:nRSG0782Sa
    ** Dry eye is a multifactorial disease caused by underlying
inflammation resulting in the lack of lubrication and moisture
on the surface of the eye
    

 (Reporting by Tanishaa Nadkar in Bengaluru)
 ((RM: tanishaa.nadkar@thomsonreuters.com))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.